This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Canfeng Liu - Innovator in Biopharmaceuticals
Introduction
Canfeng Liu is an accomplished inventor based in Hangzhou, China. He is currently associated with Adlai Nortye Biopharma Co., Ltd., where he contributes to the field of biopharmaceuticals. His work focuses on developing innovative solutions for various medical conditions.
Latest Patent Applications
Canfeng Liu has submitted a patent application titled "WNT PATHWAY INHIBITOR COMPOUNDS." This application presents a compound of formula I or a pharmaceutically acceptable salt, isotope derivative, or stereoisomer thereof, which exhibits excellent Wnt pathway inhibitory activity. The disclosure also outlines a method for preparing the compound and its potential use in preventing and/or treating cancer, tumors, inflammatory diseases, autoimmune diseases, or immune-mediated diseases.
Conclusion
Canfeng Liu's contributions to biopharmaceutical innovation highlight his commitment to advancing medical science. His ongoing research and patent applications reflect his dedication to finding effective treatments for serious health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile